Connect with us

Business Partnerships

Primitive, Co-Owned by Two Ex-Detroit Lions, and Harvard to Research Medicinal Cannabis Use

Andie Francese



Primitive, Co-Owned by Two Ex-Detroit Lions, and Harvard to Research Medicinal Cannabis Use
- Ad -
  • Primitive was created by two former Detroit Lions players.
  • Multiple athletes have worked to make the cannabis industry a part of professional sports healing.

Calvin Johnson and Rob Sims are both former members of Detroit Lions, and they co-own Primitive, a medical cannabis company. In an effort to provide a better experience for users, the co-owners are creating a partnership with Harvard University, according to reports from ESPN. The new partnership will allow them to research the impact that cannabis has on chronic traumatic encephalopathy (CTE) and pain management.

In this deal, there’s a six-figure donation to the International Phytomedicines and Medical Cannabis Institute, but the full amount has not been disclosed. The medical research will be performed by the university, as well as the clinical trials. Products developed by Primitive will receive quality assurance testing by the medical school at Harvard.

Speaking with ESPN, Sims stated,

“Really just being able to help people. I’m a second-generation NFL kid, both my father and father-in-law. I’ve seen the good, the bad and the ugly of what it looks like when you’re done playing ball. If we can help this facet of people suffering from CTE or other cognitive disease, that’s the real goal here.”

He added that the company is aiming to use the information gathered in the study to develop plant-based medicines, and that nanotechnology can soothe areas in the brain that have been impacted by CTE.

Primitive was originally created two years ago, when cannabis-related real estate piqued the interest of Sims and Johnson. Following Primitive’s approval to open a medical cannabis dispensary in Michigan, Johnson joined the Michigan Cannabis Industry Association board.

Ricky Williams, a former running back in the National Football League, launched a brand of cannabis last year. Eugene Monroe took this industry a step further in 2016, urging the league to take cannabis off the banned substances league and financially support research as part of cannabis CTE treatment. However, Monroe stated that he was unable to “say for sure” if his release from the Baltimore Ravens was due to his activism.

Mike James, a free agent running back, was denied an exemption by the league for using cannabis as a way to soothe pain last year. However, this year is turning out to be substantially different, as James announced that a Joint Pain Management Committee was being created by the league and the player’s union. This committee will be researching the effect that cannabis has on pain management, as well as investigating alternative therapies.

Andie Francese is a professional content consultant living in New York. In her copywriting career, as the leader of a group of award-winning journalists, Andrea was always gifted in organizing and optimizing teams of all sizes into creating and crafting valuable guides and insightful information into the topics presented to her acclaimed status. TOC is very excited to have her as part of our growing team.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.